Nuveen LLC Purchases New Position in Silicon Laboratories, Inc. $SLAB

Key Points

• Nuveen LLC acquired 287,266 shares of Silicon Laboratories, Inc. during Q1, valued at approximately $32.34 million, which represents a 0.88% ownership stake in the company.
• Silicon Laboratories reported a 32.6% increase in revenue year-over-year, achieving $192.85 million for the quarter, and surpassed EPS estimates.
• Wall Street analysts have varied ratings and price targets for Silicon Laboratories, with the average target now set at $151.13, reflecting a consensus of "Moderate Buy."

Nuveen LLC bought a new position in Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 287,266 shares of the semiconductor company's stock, valued at approximately $32,338,000. Nuveen LLC owned about 0.88% of Silicon Laboratories at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Skandinaviska Enskilda Banken AB publ bought a new position in shares of Silicon Laboratories in the first quarter valued at approximately $34,000. UMB Bank n.a. lifted its stake in Silicon Laboratories by 111.3% during the first quarter. UMB Bank n.a. now owns 336 shares of the semiconductor company's stock valued at $38,000 after purchasing an additional 177 shares during the last quarter. Parallel Advisors LLC lifted its position in shares of Silicon Laboratories by 143.7% in the 1st quarter. Parallel Advisors LLC now owns 463 shares of the semiconductor company's stock valued at $52,000 after acquiring an additional 273 shares in the last quarter. Larson Financial Group LLC purchased a new stake in shares of Silicon Laboratories in the 1st quarter valued at approximately $55,000. Finally, TD Private Client Wealth LLC lifted its position in shares of Silicon Laboratories by 53.6% in the 1st quarter. TD Private Client Wealth LLC now owns 914 shares of the semiconductor company's stock valued at $103,000 after acquiring an additional 319 shares in the last quarter.

Silicon Laboratories Price Performance

NASDAQ:SLAB traded up $8.1530 during midday trading on Friday, reaching $143.1730. The stock had a trading volume of 88,848 shares, compared to its average volume of 404,655. Silicon Laboratories, Inc. has a 1-year low of $82.82 and a 1-year high of $160.00. The firm's fifty day simple moving average is $138.95 and its 200-day simple moving average is $127.88. The stock has a market capitalization of $4.70 billion, a P/E ratio of -44.30 and a beta of 1.48.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last posted its earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.09 by $0.02. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The business had revenue of $192.85 million for the quarter, compared to analyst estimates of $192.57 million. During the same period last year, the business posted ($0.56) EPS. Silicon Laboratories's revenue was up 32.6% compared to the same quarter last year. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. On average, equities research analysts anticipate that Silicon Laboratories, Inc. will post -0.97 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on SLAB. KeyCorp upped their price target on shares of Silicon Laboratories from $160.00 to $180.00 and gave the company an "overweight" rating in a research report on Tuesday, July 8th. Morgan Stanley reduced their price target on shares of Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating for the company in a research report on Wednesday, August 6th. Barclays increased their target price on shares of Silicon Laboratories from $100.00 to $130.00 and gave the stock an "equal weight" rating in a research report on Tuesday, August 5th. Needham & Company LLC reiterated a "buy" rating and issued a $150.00 target price on shares of Silicon Laboratories in a research report on Wednesday, May 14th. Finally, Benchmark reiterated a "buy" rating and issued a $160.00 target price on shares of Silicon Laboratories in a research report on Tuesday, May 27th. Five analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $151.13.

Insider Transactions at Silicon Laboratories

In other Silicon Laboratories news, SVP Brandon Tolany sold 2,270 shares of the firm's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $132.69, for a total value of $301,206.30. Following the sale, the senior vice president directly owned 62,328 shares in the company, valued at $8,270,302.32. This trade represents a 3.51% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 1.60% of the stock is owned by corporate insiders.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.